0,00 $
75,00 %
Nasdaq, 16. Februar, 15:30 Uhr
ISIN
US4448632038
Symbol
HGEN
Berichte
Sektor
Industrie

Humanigen Inc Aktie News

Negativ
InvestorPlace
etwa 2 Monate alt
Humanigen (OTCMKTS: HGEN ) stock is falling hard on Friday after the company filed for Chapter 11 bankruptcy protection. This bankruptcy filing comes after Humanigen failed to secure regulatory approval for its Covid-19 treatment lenzilumab.
Negativ
Reuters
etwa 2 Monate alt
Drug developer Humanigen HGEN.PK has filed for voluntary Chapter 11 bankruptcy, according to a court filing, after struggling to get regulatory approval for its COVID-19 treatment.
Negativ
Proactive Investors
7 Monate alt
Humanigen Inc shares have plummeted more than 90% over the past month, and now trades at a little over a penny per share, after the clinical-stage biopharmaceutical company said it is facing bankruptcy after negotiations for a reverse merger with an unnamed, privately-held biopharma company ended.   Humanigen noted that it is unable to find another source of financing that would allow it to mai...
Neutral
PennyStocks
10 Monate alt
Best penny stocks to buy now? 3 to watch in the stock market today.
Neutral
PRNewsWire
mehr als ein Jahr alt
NEW YORK , Oct. 25, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Humanigen, Inc. (NASDAQ: HGEN) alleging that the Company violated federal securities laws. Class Period: May 16, 2020 to July 12, 2022 Lead Plaintiff Deadline: October 25, 2022 No obligation or cost to you.
Neutral
PRNewsWire
mehr als ein Jahr alt
NEW YORK , Oct. 24, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Humanigen, Inc. (NASDAQ: HGEN) between May 16, 2020 and July 12, 2022, both dates inclusive (the "Class Period") of the important October 25, 2022 lead plaintiff deadline. SO WHAT: If you purchased Humanigen securities during the Class Period you may be entitl...
Neutral
PRNewsWire
mehr als ein Jahr alt
NEW YORK , Oct. 24, 2022 /PRNewswire/ -- Attention Humanigen, Inc. ("Humanigen") (NASDAQ: HGEN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between May 16, 2020 and July 12, 2022. If you suffered a loss on your investment in Humanigen, contact us about potential recovery by using the link below.
Neutral
PRNewsWire
mehr als ein Jahr alt
NEW YORK , Oct. 21, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Humanigen, Inc. (NASDAQ: HGEN). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/humanigen-inc-loss-submission-form/?id=32774&from=4 The lawsuit seeks to recover losses for shareholders who purchased H...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen